| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
IO Biotech, Inc.
13D/A
IOBTQ · 449778109
|
27.4% |
6/2/2026
Event 3/31/2026
|
||||
| Schedule 13G · 1 security · passive | ||||||
|
OnKure Therapeutics, Inc.
13G/A
OKUR · 68277Q105
|
1.6% |
2/6/2025
Event 12/31/2024
|
||||
| Lundbeckfond Invest A/S | 1.6% | |||||
| Lene Skole | 1.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.